Prot# 11728 :An uncontrolled, open-label phase II study in subjects with metastatic adenocarcinoma of the colon or rectum who are receiving first line chemotherapy with mFOLFOX6 (oxaliplatin/folinic acid/5-flourouracil [5-FU]) in combination with regorafe

Project: Research project

Project Details

StatusFinished
Effective start/end date3/30/11 → 3/30/14

Funding

  • Bayer HealthCare Pharmaceuticals, Inc. (11728)